Evidence map›Paper›PMID 41413298›Full record

GuidelineSurgical endoscopy2026

EAES, ESCP, and ESGAR clinical practice guideline update on taTME for rectal cancer.

Bright Huo, Alberto Arezzo, Dana Sochorova, Amy Boyle, Yegor Tryliskyy, Iro Ntaga, Dimitris Mavridis, Michel Adamina, Patricia Sylla, Rosa Jiménez-Rodriguez and 7 more

Erratum issuedAbstract readPractice GuidelineSystematic Review
PubMed Publisher
In one paragraph

Guideline in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Bright HuoDivision of General Surgery, Department of Surgery, McMaster University, Hamilton, Canada.ORCID 0000-0003-4999-4328
Alberto Arezzo *Department of Surgical Sciences, University of Torino, Turin, Italy.
Dana SochorovaDepartment of Surgery, Tomas Bata Hospital Zlin, Zlin, Czech Republic.
Amy BoyleMichael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
Yegor TryliskyySouthmead Hospital, Bristol, UK.
Iro NtagaDepartment of Primary Education, School of Education, University of Ioannina, Ioannina, Greece.
Dimitris MavridisDepartment of Primary Education, School of Education, University of Ioannina, Ioannina, Greece.
Michel AdaminaDepartment of Surgery, Cantonal Hospital of Fribourg and Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
Patricia SyllaDivision of Colon and Rectal Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Rosa Jiménez-RodriguezDepartment of General Surgery, Colorectal Unit, Hospital Universitario Virgen del Rocio, Seville, Spain.
Dimitris NtourakisDivision of Surgery, School of Medicine, European University Cyprus, Nicosia, Cyprus.
Dorin PopaDepartment of Surgery, Linköping University Hospital, Linköping, Sweden.
Audrius DulskasDepartment of Surgery, National Cancer Institute (Lithuania), Vilnius, Lithuania.
Sofia GourtsoyianniDepartment of Radiology, School of Medicine, National and Kapodistrian University of Athens, Areteion Hospital, Athens, Greece.
Vincenzo VillanacciInstitute of Pathology, ASST Spedali Civili and University of Brescia, Brescia, Italy.
Ivan D FlorezDepartment of Pediatrics, University of Antioquia, Medellin, Colombia.
Stavros A Antoniou *Guidelines Committee, European Association for Endoscopic Surgery, Eindhoven, Netherlands. stavros.antoniou@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe EAES released guidelines on the role of taTME in the management of rectal cancer in 2022.

objectiveTo develop updated, evidence-informed recommendations to support clinicians involved in the management of taTME; to provide guidance for hospital managers, policymakers, and patients with low- and mid-rectal cancers.

methodsWe performed a systematic review to identify randomized trials and matched nonrandomized studies comparing transanal total mesorectal excision (taTME) to laparoscopic TME (laTME) or robotic TME (roTME) in patients with low- and mid-rectal cancer. A panel of general and colorectal surgeons, a radiologist, a pathologist, and patient partners appraised the certainty of the evidence using GRADE. The panel developed recommendations using an evidence-to-decision framework during an in-person consensus meeting. We applied a Delphi survey to establish consensus.

resultsThe panel recommends taTME over laTME in patients with low- and selected mid-rectal cancers when access to surgeons with expertise in performing taTME in high-volume rectal cancer centers is available (strong recommendation). This recommendation applies to patients eligible for sphincter preservation who are at high risk for conversion to abdominoperineal resection, including male gender with BMI > 30 kg/m

conclusionWe provide evidence-informed guidance on the role of taTME in the surgical management of patients with low- and mid-rectal cancers. Patients and surgeons should exercise shared-decision making to apply patient-tailored decisions when considering treatment options.

Indexed as

LaparoscopyProctectomyRectal NeoplasmsRobotic Surgical ProceduresTransanal Endoscopic SurgeryHumansLaparoscopic TMElaTMERectal cancerRobotic TMEroTMEtaTMETransanal TME

Identifiers

PMID41413298

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.